Novo Nordisk

The acquisition of Inversago includes the company’s lead development asset INV-202, an oral CB1 inverse agonist

Vikrant Shrotriya, CVP & MD, Novo Nordisk India in an interaction with Express Pharma growth opportunities in pharma sector…

This week-long summer camp will host 100 exceptional students coming together from across the world  

Orchestrate a 90-minute ride from Bandra to Worli in Mumbai to highlight how obesity is becoming a public health concern all over…

Vikrant Shrotriya, MD and CVP, Novo Nordisk India, talks to Express Pharma about the potential and opportunities that the Indian…

The company is in a drawn-out production revamp after a contractor filling Wegovy injection pens ran into problems late last year

Ozempic demonstrated 2.1 per cent blood sugar reduction and also weight loss in adults with type-II diabetes with new 2 mg dose

Civica, launched in 2018 to make generic drugs, said it would produce three copycat versions of insulin

Following the expiration of Novo Nordisk’s cash tender offer for Dicerna, Novo Nordisk has acquired all outstanding shares of…

Lene Hylling Axelsson, Corporate Vice President, Global Business Services, Novo Nordisk shares details about the milestones and…